Description

Diphenylmethyl7-(3,5-Di-tert-Butyl-4-Hydroxybenzylideneamino)-3-[[(1-Methyl-1H-Tetrazol-5-Yl)Thio]Methyl]-3-Cephem-4-Carboxylate is a sophisticated, non-natural cephalosporin derivative and a key advanced pharmaceutical intermediate. This compound is engineered to serve as a crucial building block in the synthesis of next-generation β-lactam antibiotics, offering a pathway to novel therapeutic agents with potentially enhanced efficacy and resistance profiles. It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing innovative anti-infective drugs.

Application

• Pharmaceutical Intermediate: A critical precursor in the research and synthesis of novel cephalosporin-class antibiotics.
• Antibacterial Drug Development: Used in medicinal chemistry programs aimed at creating new agents to combat drug-resistant bacterial infections.
• Biochemical Research: Serves as a reference standard or probe compound in studies of β-lactamase inhibition and bacterial cell wall synthesis.
• Fine Chemical Synthesis: Employed in multi-step organic syntheses to introduce complex cephem structures into target molecules.

Basic Information

Product Name	Diphenylmethyl7-(3,5-Di-tert-Butyl-4-Hydroxybenzylideneamino)-3-[[(1-Methyl-1H-Tetrazol-5-Yl)Thio]Methyl]-3-Cephem-4-Carboxylate
CAS No.	58844-13-6
Molecular Formula	C39H44N6O4S
Molecular Weight	692.87 g/mol
Synonyms	Diphenylmethyl 7-[(3,5-Di-tert-butyl-4-hydroxybenzylidene)amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-3-cephem-4-carboxylate; 7-[(3,5-Di-tert-butyl-4-hydroxybenzylidene)amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-3-cephem-4-carboxylic Acid Diphenylmethyl Ester; Cephalosporin Derivative 58844-13-6; (6R,7R)-7-[(E)-[(3,5-Di-tert-butyl-4-hydroxyphenyl)methylidene]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Benzhydryl Ester
EINECS	Contact for details

Quality Control

Our production of this high-value intermediate adheres to strict quality management systems to ensure batch-to-batch consistency and purity. Each lot is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This compound is light-sensitive (store away from light) and may be hygroscopic (moisture-sensitive); therefore, containers should be kept tightly sealed under inert atmosphere when not in use to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.